Clomid Side Effects: Complete Guide to Risks, Frequency & Management

Clomid side effects range from mild and self-limiting — hot flashes, bloating, mood swings — to rare but serious events such as ovarian hyperstimulation syndrome and visual disturbances. Clomiphene citrate (brand name Clomid) has been an ovulation-induction mainstay since FDA approval in 1967 and remains a first-line option for many people with PCOS and unexplained anovulation. This guide breaks down what published evidence and FDA labeling say about each side effect category — how often it happens, how long it lasts, and when symptoms warrant a call to a prescribing clinician. Nothing here replaces personalized medical advice; treatment decisions belong with the clinician who knows your history.

Key facts at a glance

• Hot flashes hit roughly 10-20% of users — the most common Clomid side effect.
• Twin pregnancy rate is approximately 7-10% per Clomid cycle; higher-order multiples remain under 1%.
• OHSS with Clomid monotherapy occurs in fewer than 1% of cycles.
• Visual disturbances (1-2% of users) require immediate discontinuation per the FDA label.

What are the most common Clomid side effects?

The most common Clomid side effects are vasomotor and gastrointestinal in nature. Per the FDA prescribing information for clomiphene citrate, hot flashes occur in approximately 10% of patients, abdominal discomfort or bloating in about 5.5%, breast discomfort in around 2.1%, nausea or vomiting in about 2.2%, and headaches in approximately 1.3%¹. Real-world clinical experience tends to put hot flash incidence slightly higher (10-20%) because patients often under-report milder cases in trial settings.

These effects are tied to Clomid's mechanism: it is a selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the hypothalamus, causing a transient rise in FSH and LH to stimulate ovulation. The brain interprets the receptor blockade as a low-estrogen state, which is why side effects resemble perimenopausal symptoms². Most resolve within 1-2 weeks of completing the standard 5-day course at 50-150 mg per day.

A 2013 ASRM committee opinion notes that side effects are dose-dependent — patients on 150 mg report more vasomotor and mood symptoms than those on 50 mg — but efficacy plateaus above 100 mg in most patients, so escalating dose for ovulation often increases side effects without much added benefit².

How Clomid affects ovaries, mood, and vision

Ovarian effects and OHSS risk

Clomid stimulates the ovaries to recruit multiple follicles. Mild ovarian enlargement is common — ultrasound studies show measurable cyst formation in roughly 15% of cycles, though most resolves spontaneously within one menstrual cycle¹. True ovarian hyperstimulation syndrome (OHSS), characterized by ascites, hemoconcentration, and risk of thromboembolism, is rare with Clomid alone: severe OHSS occurs in well under 1% of monotherapy cycles³. Risk rises substantially when Clomid is combined with injectable gonadotropins or an hCG trigger shot in IUI/IVF protocols.

Mood and cognitive side effects

Mood-related side effects affect roughly 5-10% of users. Reported symptoms include irritability, tearfulness, anxiety, and depressive feelings. The 2014 PPCOS-II trial of 750 PCOS patients comparing letrozole to clomiphene found mood symptoms higher in the Clomid arm³. Patients with pre-existing depression or anxiety disorders should disclose this to the prescribing clinician before starting; some clinicians prefer letrozole as first-line for PCOS partly because of this profile.

Visual disturbances

Visual side effects — blurred vision, flashing lights, scotomas (blind spots), and prolonged afterimages — affect approximately 1-2% of users⁶. The FDA label is explicit: visual symptoms are an indication to stop Clomid immediately and notify the prescriber¹. While most cases reverse within days to weeks of discontinuation, persistent visual changes have been documented and may require ophthalmologic evaluation⁶. Visual disturbances appear dose-related and more common at 100-150 mg daily.

Treatment, monitoring, and alternatives

Standard Clomid protocols use 50-150 mg daily for 5 days starting on cycle day 3, 4, or 5. Monitoring varies by clinic but typically includes a baseline ultrasound, mid-cycle follicle tracking, and either ovulation predictor kit confirmation or a mid-luteal progesterone check. Patients are usually advised against more than 6 ovulatory cycles total because of theoretical concerns about long-term endometrial effects, though current evidence does not strongly support an ovarian cancer link².

For PCOS specifically, the 2023 international evidence-based PCOS guideline now recommends letrozole as first-line ovulation induction over Clomid, based on the PPCOS-II trial showing higher live birth rates (27.5% vs 19.1%) and lower multiple pregnancy rates with letrozole³⁸. Clomid remains widely used because of cost, familiarity, and oral dosing. Metformin, lifestyle modification, and gonadotropins are other options that may be discussed with a clinician. Combination regimens (Clomid + metformin) show modest live birth benefit in some PCOS subgroups⁸. Any decision to switch agents, escalate dose, or move to assisted reproduction should be made with a reproductive endocrinologist or OB/GYN who has reviewed the full history.

Telehealth options for PCOS and ovulation support

Several telehealth providers offer PCOS-focused care that includes Clomid prescribing or referrals, though scope varies by state and clinician licensing. Allara operates a multidisciplinary PCOS-specialty model with endocrinologists, dietitians, and gynecology services, and accepts several commercial insurance plans. Pollie focuses on root-cause workups for PCOS with hormone panels and lifestyle coaching; medication management is referral-based in some states. Felix Health PCOS offers asynchronous PCOS visits with prescribing clinicians for first-line therapies. MS Medicine provides clinician-led metabolic and hormone care relevant to PCOS-associated insulin resistance.

Most telehealth PCOS programs require a baseline ultrasound and labs that they coordinate with local providers. Prescribing of Clomid via telehealth specifically is regulated state by state — confirm with the platform whether ovulation induction is in their formulary. Some brand mentions on this page link to our editorial reviews; we may earn a commission if you sign up via those links.

Safety, contraindications, and when to call a doctor

Per the FDA label, Clomid is contraindicated in patients with liver disease or a history of hepatic dysfunction, abnormal uterine bleeding of undetermined origin, ovarian cysts not from PCOS, uncontrolled thyroid or adrenal dysfunction, and known or suspected pregnancy¹. The drug is FDA Pregnancy Category X — it should be stopped before conception is confirmed.

Symptoms that warrant urgent contact with a clinician include:

• Severe pelvic or abdominal pain (possible OHSS or ovarian torsion)
• Rapid weight gain of more than 5 pounds in days, or marked abdominal swelling (OHSS)
• Shortness of breath, leg swelling, or chest pain (thromboembolism risk in severe OHSS)
• Any visual disturbance — flashes, blurred vision, blind spots¹
• Persistent severe headache or one-sided neurological symptoms

The ACOG PCOS bulletin emphasizes that pre-treatment evaluation should include a thorough cardiovascular and metabolic assessment, since PCOS itself carries elevated risk for hypertension and dyslipidemia that affects medication choices⁵. Cancer risk has been studied extensively; large cohort analyses have not established a causal link between Clomid use and ovarian or breast cancer, though long-duration use (>12 cycles) is generally discouraged⁴.

Cost and insurance considerations

Generic clomiphene citrate is among the most affordable fertility medications. A typical 5-day cycle (50 mg) costs roughly $10-$50 cash-pay at U.S. retail pharmacies, and GoodRx-style discount programs often bring it under $20. Brand-name Clomid is rarely stocked anymore. Compared with letrozole (similar pricing) or injectable gonadotropins ($1,500-$5,000 per cycle), oral ovulation induction is the budget-friendly entry point⁴.

Insurance coverage of fertility medications varies widely. Some commercial plans cover Clomid under standard pharmacy benefits because it has non-fertility uses (luteal phase support), while others require a fertility rider. Twenty-one U.S. states had some form of fertility insurance mandate as of 2024, but mandate scope ranges from diagnostic-only to full IVF cycles. Monitoring costs — baseline and mid-cycle ultrasounds, progesterone labs — add $200-$800 per cycle out of pocket if uncovered. Patients should ask telehealth platforms and local clinics for itemized estimates before starting therapy.

Frequently asked questions

What are the most common clomid side effects? The most frequently reported clomid side effects are hot flashes (around 10-20%), mood swings and irritability (around 5-10%), breast tenderness, bloating, nausea, and headaches. Most resolve within days of finishing the 5-day course. Visual changes are uncommon but require stopping the medication.

How long do Clomid side effects last? Most physical Clomid side effects — hot flashes, bloating, mood changes — resolve within 1-2 weeks of finishing the typical 5-day cycle, as estrogen receptors are no longer blocked. Visual disturbances usually reverse within days to weeks after stopping but should always be reported to a clinician immediately.

Does Clomid cause weight gain? Clomid is not commonly associated with sustained weight gain. Temporary bloating from ovarian enlargement and fluid retention can mimic 1-3 pounds of weight increase during a cycle, but this typically resolves after menses. Persistent weight gain warrants discussion with a clinician about other causes.

Can Clomid cause anxiety or depression? Mood-related side effects including anxiety, irritability, tearfulness, and depressive symptoms are reported by roughly 5-10% of users. Patients with pre-existing mood disorders should discuss baseline status with their prescribing clinician before starting, as Clomid's estrogen-receptor modulation can amplify mood symptoms.

What is OHSS and how often does it happen with Clomid? Ovarian hyperstimulation syndrome (OHSS) is a complication where ovaries swell and leak fluid. With Clomid monotherapy, severe OHSS occurs in under 1% of cycles. Risk increases when Clomid is combined with injectable gonadotropins or hCG triggers. Severe abdominal pain, rapid weight gain, or shortness of breath needs urgent care.

Why does Clomid cause hot flashes? Clomid (clomiphene citrate) is a selective estrogen receptor modulator that blocks estrogen receptors in the hypothalamus. The brain interprets this as low estrogen and triggers thermoregulatory responses similar to menopausal hot flashes. The effect is dose-dependent and typically resolves after the 5-day course ends.

Sources

1. U.S. Food and Drug Administration. Clomiphene citrate (Clomid) prescribing information. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf>
2. Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100(2):341-348. <https://pubmed.ncbi.nlm.nih.gov/23809505/>
3. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119-129. <https://pubmed.ncbi.nlm.nih.gov/25006718/>
4. Homburg R. Clomiphene citrate — end of an era? A mini-review. Hum Reprod. 2005;20(8):2043-2051. <https://pubmed.ncbi.nlm.nih.gov/15878925/>
5. American College of Obstetricians and Gynecologists. Polycystic Ovary Syndrome: ACOG Practice Bulletin No. 194. Obstet Gynecol. 2018;131(6):e157-e171. <https://pubmed.ncbi.nlm.nih.gov/29794677/>
6. Purvin VA. Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol. 1995;113(4):482-484. <https://pubmed.ncbi.nlm.nih.gov/7710399/>
7. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility. N Engl J Med. 2015;373(13):1230-1240. <https://pubmed.ncbi.nlm.nih.gov/26398071/>
8. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. Monash University & ESHRE. <https://pubmed.ncbi.nlm.nih.gov/37580934/>

Related brands & guides

• Allara — multidisciplinary PCOS care
• Pollie — root-cause PCOS workups
• Felix Health PCOS — async PCOS visits
• MS Medicine — metabolic and hormone care

Updated 2026-05-29. Reviewed by Dr. Maya Chen, MD, NAMS-CMP.